☆ 4.7 Review

Identification of Drug Interaction Adverse Events in Patients With COVID-19 A Systematic Review

JAMA NETWORK OPEN (2022)

Related references

Note: Only part of the references are listed.

Review Pharmacology & Pharmacy

An overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)

Pasquale Pagliano et al.

Summary: Remdesivir is a widely investigated antiviral drug for treating COVID-19, showing promising activity against SARS-CoV-2 in vitro studies by suppressing viral replication. However, its efficacy in reducing mortality has not been clearly demonstrated.

EXPERT OPINION ON DRUG DISCOVERY (2022)

Add to Collection

Article Immunology

A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post-kidney transplant recipient

Theerachai Thammathiwat et al.

Summary: A case of COVID-19 in a kidney transplant patient in Thailand is reported. The patient's symptoms improved after receiving high-flow nasal cannula oxygen therapy and antiviral treatment, but reversible acute kidney injury occurred due to drug interaction between tacrolimus and antiviral treatment.

TRANSPLANT INFECTIOUS DISEASE (2021)

Add to Collection

Article Medicine, General & Internal

Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactions

Giada Crescioli et al.

Summary: This study aimed to describe the clinical and pharmacological characteristics of SARS-CoV-2 hospitalized patients, focusing on ADRs, particularly those related to drug-drug interactions (DDIs). Among the 23 Caucasian patients during the study period, most were exposed to polypharmacy, and 17.4% had comorbidities. ADRs mainly involved cardiovascular, psychiatric, and gastrointestinal disorders, with a high incidence of QT prolongation. ADRs improved or resolved completely in 60.8% of cases.

INTERNAL AND EMERGENCY MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection

Etienne Meriglier et al.

Summary: In patients with COVID-19 who received combination therapy with hydroxychloroquine and Lopinavir or darunavir, 17% experienced ECG abnormalities, which were mainly associated with age or a history of cardiovascular disease.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Add to Collection

Article Microbiology

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

Wendy P. Painter et al.

Summary: Molnupiravir showed rapid appearance and dose-proportional increase in plasma, with good tolerability in healthy volunteers. The study evaluated single and multiple doses of molnupiravir and the impact of food on pharmacokinetics in subjects, showing no accumulation following multiple doses and a decrease in absorption rate when administered with food, but no decrease in overall exposure.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Add to Collection

Article Chemistry, Medicinal

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective

Simone Perazzolo et al.

Summary: The COVID-19 pandemic has caused widespread infections and deaths globally, highlighting the importance of social distancing measures and vaccines. However, pharmacological interventions are also crucial in limiting disease severity and mortality, necessitating the development of effective antivirals and immunoregulatory agents.

JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Add to Collection

Article Multidisciplinary Sciences

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen et al.

Summary: PF-07321332, an orally bioavailable SARS-CoV-2 main protease inhibitor, has been discovered with in vitro pan-human coronavirus antiviral activity and excellent off-target selectivity and in vivo safety profiles. This new drug has shown promise in countering the threat of COVID-19 with its oral activity and safety in clinical trials.

SCIENCE (2021)

Add to Collection

Review Infectious Diseases

Characteristics of viral pneumonia in the COVID-19 era: an update

P. Pagliano et al.

Summary: Viral pneumonia caused by influenza virus, rhinovirus, adenovirus, and coronavirus is a significant cause of community-acquired pneumonia, particularly in extreme age groups. Severe cases can result in respiratory failure, with the elderly and cancer patients being at higher risk of adverse outcomes.

INFECTION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template

Calvin J. Gordon et al.

Summary: The study found that Molnupiravir or NHC can increase the mutation frequencies in replicating coronaviruses, leading to enhanced antiviral effects; NHC-TP primarily competes with CTP for incorporation, resulting in RNA mutations; Biochemical data support a mechanism of action of Molnupiravir that is primarily based on RNA mutagenesis mediated via the template strand.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Add to Collection

Article Health Care Sciences & Services

Acute Pain Crisis Caused by Tramadol Remdesivir Drug-Drug Interaction

Dac Teoli et al.

Summary: Drug interactions can affect patient outcomes, and drugs approved for emergency use undergo less preapproval testing. Both tramadol and remdesivir are prodrugs, with tramadol requiring metabolism and remdesivir undergoing intracellular conversions.

JOURNAL OF PALLIATIVE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain

M. D. Cantudo-Cuenca et al.

Summary: The study aimed to evaluate the prevalence and severity of drug-drug interactions in COVID-19 therapies and concomitant medications, finding a high rate of real and potential DDIs among hospitalized patients. Both comorbidities and polypharmacy were independently associated with the development of DDIs, highlighting the importance of monitoring and managing interactions in clinical practice.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Health Care Sciences & Services

Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis

Valeria Conti et al.

Summary: The meta-analysis suggests that Tocilizumab may reduce mortality in COVID-19 patients. While observational studies showed a significant reduction in mortality with Tocilizumab, there was no similar effect found in RCTs. Personalizing therapy based on patient characteristics is essential.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Hematology

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients

Steven P. Treon et al.

BLOOD (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Spectrum of Cardiac Manifestations in COVID-19 A Systematic Echocardiographic Study

Yishay Szekely et al.

CIRCULATION (2020)

Add to Collection

Article Immunology

Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19)

Marilu Bartiromo et al.

TRANSPLANT INFECTIOUS DISEASE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Archana Ramireddy et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Add to Collection

Article Oncology

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab

Emre Yekeduz et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2020)

Add to Collection

Article Medicine, General & Internal

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial

Mayla Gabriela Silva Borba et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Neurosciences

Intracranial hemorrhage complicating anticoagulant prophylactic therapy in three hospitalized COVID-19 patients

Muhammad Usman Ghani et al.

JOURNAL OF NEUROVIROLOGY (2020)

Add to Collection

Article Clinical Neurology

COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatry

G. Anmella et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Add to Collection

Article Pharmacology & Pharmacy

Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019

Xin Li et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Article Pharmacology & Pharmacy

Treatment for COVID-19: An overview

Cristina Stasi et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment

Juan Macias et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics

Valeria Conti et al.

BIOMOLECULES (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia

Milo Gatti et al.

CURRENT HEART FAILURE REPORTS (2020)

Add to Collection

Review Multidisciplinary Sciences

Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis

Carlos K. H. Wong et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Infectious Diseases

Severe Thrombocytopenia in a Patient with COVID-19

Eliel Nham et al.

INFECTION AND CHEMOTHERAPY (2020)

Add to Collection

Review Oncology

Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib

Khai Li Chai et al.

LEUKEMIA & LYMPHOMA (2017)

Add to Collection

Article Oncology

Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients

Alexandre Chan et al.

SUPPORTIVE CARE IN CANCER (2014)

Add to Collection

Article Health Care Sciences & Services

Adverse Drug Reactions and Drug Interactions as Causes of Hospital Admission in Oncology

Vanessa Miranda et al.

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2011)

Add to Collection

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Add to Collection

Article Medicine, General & Internal

Meta-analysis of observational studies in epidemiology - A proposal for reporting

DF Stroup et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.